Washington, D.C. 20549

                                  FORM 12b-25

                          NOTIFICATION OF LATE FILING

(Check One):
Form 10-K [X] Form 20-F [] Form 11-K [] Form 10-Q [] Form N-SAR []

                For Period Ended: JUNE 30, 2002

[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR

                For the Transition Period Ended:

Read Instruction (on back page) Before Preparing Form.  Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:


        Full Name of Registrant:                        CellPoint Inc.

        Former Name if Applicable:

        Address of Principal Executive Office (Street and Number):

        3000 Hillswood Drive, Hillswood Business Park

        City, State and Zip Code:
        Chertsey, Surrey, KT16 0RS

PART II-RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following
should be completed. (Check box if appropriate)

[X]  (a)     The reasons described in reasonable detail in Part III of this form
             could not be eliminated without unreasonable effort or expense;

[X]  (b)     The subject annual report, semi-annual report, transition report on
             Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof, will be
             filed on or before the fifteenth calendar day following the
             prescribed due date; or the subject quarterly report of transition
             report on Form 10-Q, or portion thereof will be filed on or before
             the fifth calendar day following the prescribed due date; and

[X]  (c)     The accountant's statement or other exhibit required by Rule
             12b-25(c) has been attached if applicable.


State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q,
N-SAR, or the transition report or portion hereof, could not be filed within
the prescribed time period. (Attach Extra Sheets if Needed)

     We were not able to complete the required financial statements for this
     period on a timely basis. We expect to file the required report within the
     allotted extension.


(1)     Name and telephone number of person to contact in regard to this

        Shawn Rogers            312                     670-8227
        (Name)              (Area Code)             (Telephone Number)

(2)     Have all other periodic reports required under Section 13 or 15(d) of
        the Securities Exchange Act of 1934 or Section 30 of the Investment
        Company Act of 1940 during the preceding 12 months (or for such
        shorter) period that the registrant was required to file such reports)
        been filed? If answer is no, identify report(s). [X] Yes  [] No

(3)     Is it anticipated that any significant change in results of operations
        from the corresponding period for the last fiscal year will be reflected
        by the earnings statements to be included in the subject report or
        portion thereof? [] Yes [X] No

        If so, attach an explanation of the anticipated change, both
        narratively and quantitatively, and, if appropriate, state the reasons
        why a reasonable estimate of the results cannot be made.

                                 CELLPOINT INC.
                  (Name of Registrant as Specified in Charter)

   has caused this notification to be signed on its behalf by the undersigned
                           hereunto duly authorized.

Date    September 30, 2002               By    /s/ Stephen T. Childs
                                                   Stephen T. Childs
                                                   Chief Executive Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority
to sign on behalf of the registrant shall be filed with the form.

Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).

                              GENERAL INSTRUCTIONS

1.      This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General
        Rules and Regulations under the Securities Exchange Act of 1934.

2.      One signed original and four conformed copies of this form and
        amendments thereto must be completed and filed with the Securities and
        Exchange Commission, Washington, D.C. 20549, in accordance with Rule 0-3
        of the General Rules and Regulations under the Act. The information
        contained in or filed with the form will be made a matter of public
        record in the Commission files.

3.      A manually signed copy of the form and amendments thereto shall be filed
        with each national securities exchange on which any class of securities
        of the registrant is registered.

4.      Amendments to the notifications must also be filed on form 12b-25 but
        need not restate information that has been furnished. The form shall be
        clearly identified as an amended notification.